New Development of Medicines for Priority Diseases in Africa

The Lancet- United Kingdom

doi 10.1016/s0140-6736(16)31544-6

Full Text

Abstract

Available in

Categories

Date

September 1, 2016

Authors

Bartholomew D Akanmori

David O Mukanga

Vincent Ahonkhai

Matshidiso R Moeti

Publisher

Elsevier BV

Related search

Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists

Multidisciplinary

English

New Life Priority System and Innovetion Development

Interexpo GEO-Siberia

English

Pharmacovigilance of Medicines for Rare and Ultrarare Diseases

Therapeutic Advances in Drug Safety

English

Development Priority

Basic and Clinical Pharmacology and Toxicology

English

Availability, Pricing and Affordability of Selected Medicines for Noncommunicable Diseases

Eastern Mediterranean Health Journal

English

The European Medicines Agency's Approval of New Medicines for Type 2 Diabetes

Diabetes, Obesity and Metabolism

Internal Medicine

English

Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency

English

History of Development and Regulations for Regenerative Medicines in Japan

Journal of Stem Cell Research & Therapy

English

Priority Based New Approach for Correlation Clustering

International Journal of Information Technology and Computer Science

English